These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21977881)

  • 1. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?
    Rodrigue JR; Nelson DR; Reed AI; Hanto DW; Curry MP
    Prog Transplant; 2011 Sep; 21(3):207-14. PubMed ID: 21977881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
    JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
    Attia A; Webb J; Connor K; Johnston CJC; Williams M; Gordon-Walker T; Rowe IA; Harrison EM; Stutchfield BM
    Lancet Healthy Longev; 2024 May; 5(5):e346-e355. PubMed ID: 38705152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Precise Relationship Between Model for End-Stage Liver Disease and Survival Without a Liver Transplant.
    VanDerwerken DN; Wood NL; Segev DL; Gentry SE
    Hepatology; 2021 Aug; 74(2):950-960. PubMed ID: 33655565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for a New Predictive Model of Short-Term Mortality After Living Donor Liver Transplantation due to Acute Liver Failure.
    Chung HS; Lee YJ; Jo YS
    Ann Transplant; 2017 Feb; 22():101-107. PubMed ID: 28220036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.
    Benzing C; Krezdorn N; Förster J; Hinz A; Krenzien F; Atanasov G; Schmelzle M; Hau HM; Bartels M
    HPB (Oxford); 2016 May; 18(5):449-55. PubMed ID: 27154809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between pretransplantation liver status and health-related quality of life after grafting: a single-center prospective study.
    Kotarska K; Raszeja-Wyszomirska J; Wunsch E; Chmurowicz T; Kempińska-Podhorodecka A; Wójcicki M; Milkiewicz P
    Transplant Proc; 2014 Oct; 46(8):2770-3. PubMed ID: 25380914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation.
    Hong G; Lee KW; Suh S; Yoo T; Kim H; Park MS; Choi Y; Yi NJ; Suh KS
    J Korean Med Sci; 2013 Aug; 28(8):1207-12. PubMed ID: 23960449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
    Lai JC; Covinsky KE; Hayssen H; Lizaola B; Dodge JL; Roberts JP; Terrault NA; Feng S
    Liver Int; 2015 Sep; 35(9):2167-73. PubMed ID: 25644788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease.
    Derck JE; Thelen AE; Cron DC; Friedman JF; Gerebics AD; Englesbe MJ; Sonnenday CJ
    Transplantation; 2015 Feb; 99(2):340-4. PubMed ID: 25606782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
    Matoba D; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Doki Y; Eguchi H
    Transplant Proc; 2023 May; 55(4):893-897. PubMed ID: 37120341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.